{
  "Disease": [
    {"role": "system", "content": "You are a knowledgeable assistant specialized in recognizing and understanding named entities and their interrelations. If requested to organize information in tabular format, you are adept at filtering and presenting only the relevant and valid results. You will exclude any results that are not pertinent or are inaccurate from the table according to the discussion history."},
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph.\n\nParagraph: The results indicate that the clinical usefulness of direct , peripherally acting sub - type - selective alpha1 - adrenoceptor agonists in the medical treatment of stress incontinence may be limited by associated piloerection and cardiovascular side effects .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Based on the given paragraph, the identified \"Disease\" entity is \"stress incontinence\"."},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease            |\n|--------------------|\n| stress incontinence |"}
  ],
  "Chemical": [
    {"role": "system", "content": "You are a knowledgeable assistant specialized in recognizing and understanding named entities and their interrelations. If requested to organize information in tabular format, you are adept at filtering and presenting only the relevant and valid results. You will exclude any results that are not pertinent or are inaccurate from the table according to the discussion history."},
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph.\n\nParagraph: The results indicate that the clinical usefulness of direct , peripherally acting sub - type - selective alpha1 - adrenoceptor agonists in the medical treatment of stress incontinence may be limited by associated piloerection and cardiovascular side effects .\n\nLet's think step by step."},
    {"role": "assistant", "content": "Sure! Let's identify the \"Chemical\" entities in the given paragraph:\n\n1. direct: Not a chemical entity.\n2. peripherally acting: Not a chemical entity.\n3. sub-type-selective: Not a chemical entity.\n4. alpha1-adrenoceptor agonists: Chemical entity.\n5. stress incontinence: Not a chemical entity.\n6. piloerection: Not a chemical entity.\n7. cardiovascular: Not a chemical entity.\n8. side effects: Not a chemical entity.\n\nBased on the analysis, the only chemical entity mentioned in the paragraph is \"alpha1-adrenoceptor agonists\"."},
    {"role": "user", "content": "Please present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical                |\n|-------------------------|\n| alpha1-adrenoceptor agonists |"}
  ]
}